The Affordable Care Act (ACA) created reporting requirements under Internal Revenue Code (Code) Sections 6055 and 6056. Under these rules, certain employers must provide information to the IRS about the health plan coverage they offer (or do not offer) to their employees.
Currently, any reporting entity that is required to file at least 250 individual statements under Sections 6055 or 6056 must file electronically. However, on Feb. 23, 2023, the IRS released a final rule implementing a law change by the Taxpayer First Act of 2019, which lowers the 250-return threshold for mandatory electronic reporting to 10 returns. This means most reporting entities will be required to complete their ACA reporting electronically starting in 2024.
This ACA Compliance Bulletin describes the process for reporting electronically under Sections 6055 and 6056.
MANDATORY ELECTRONIC FILING
CURRENT THRESHOLD
Under the current reporting rules, any reporting entity that is required to file at least 250 individual statements under Sections 6055 or 6056 must file electronically.
NEW, EXPANDED THRESHOLD
Reporting entities that file at least 10 returns during the calendar year must file their ACA returns electronically beginning in 2024.
ACTION STEPS
Employers that are subject to the ACA reporting rules should begin to explore options for filing ACA reporting returns electronically. For example, they may be able to work with a third-party vendor to complete the electronic filing.
Reporting entities that may be in a position to perform their own electronic reporting can review the IRS’ ACA Information Returns (AIR) Program main page for more information on the reporting standards for composing and successfully transmitting compliant submissions to the IRS.
Related Blogs
Employee Benefits
PUBLISHED
February 20th, 2026
EBSA Updates National Employee Benefit Plan Enforcement Projects for 2026
DeAnn Deck
The Employee Benefits Security Administration (EBSA) announced updates to its national enforcement projects for fiscal year 2026. According to EBSA, these projects highlight areas ...
Read More
Benefits+
PUBLISHED
February 10th, 2026
Employer Response to Pharma Shifts
Chris Antypas
Volatility in the pharmaceutical industry, including the expanding specialty drug pipeline, increased utilization of GLP-1 medications, and persistent supply chain disruptions, are contributing to rising costs ...
Read More
Benefits+
PUBLISHED
February 9th, 2026
White House Launches TrumpRx, Unveils Drug Prices
DeAnn Deck
On Feb. 5, President Donald Trump announced the launch of TrumpRx.gov, a federally operated website to help individuals buy prescription medications at discounted cash ...
Read More
Benefits+
PUBLISHED
February 6th, 2026
DOL Issues Updated Model Employer CHIP Notice
DeAnn Deck
The U.S. Department of Labor (DOL), through its Employee Benefits Security Administration (EBSA), has released a new model Employer CHIP Notice with information current ...
Read More
Benefits+
PUBLISHED
February 5th, 2026
Prescription Drug Reporting (RxDC Report)
DeAnn Deck
The No Surprises Act (NSA), enacted as part of the Consolidated Appropriations Act, 2021 (CAA), includes transparency provisions requiring group health plans to report ...
Read More
Benefits+
PUBLISHED
February 4th, 2026
Major Federal PBM Reforms Enacted as DOL Proposes New PBM Fee-Disclosure Rule
DeAnn Deck
Federal oversight efforts directed at the pharmaceutical benefit manager (PBM) industry have expanded in recent years, culminating in several significant actions. On Feb. 3, ...
Read More